Curriculum Vitae
(Revised March 2007)
Name:
Jefferson Bruce Prince
Office Address:
Child Psychiatry
ACC 725
Massachusetts General Hospital
15 Parkman Street
Boston, MA 02114
Child Psychiatry
4th Floor
North Shore Children’s Hospital
57 Highland Avenue
Salem, MA 01970
Office Phone:
617-724-5600
978-354-2613
E-Mail:
jprince@partners.org
Date of Birth:
September 6, 1964
Place of Birth:
Columbia, South Carolina
Education:
1991
M.D., Emory University School of Medicine, Atlanta, GA
1986
B.S., Georgetown University (Biology), Washington, DC
Postdoctoral Training:
Internships and Residencies:
1991-1992
1992-1995
1994-1995
1995-1997
Transitional Internship (six months medicine, four months pediatrics, two months
neurology), Department of Medicine, Emory University Hospitals, Atlanta, GA
Resident in Psychiatry, Massachusetts General Hospital, Harvard Medical School,
Boston, MA
Chief Resident, Acute Psychiatry Service, Massachusetts General Hospital,
Harvard Medical School, Boston, MA
Clinical Fellow in Child Psychiatry, Massachusetts General and McLean
Hospitals, Harvard Medical School, Boston, MA
Licensure and Certification:
1992
1996
1996
2001
National Board of Registration in Medicine
Board of Registration, State of Massachusetts, #81600
American Board of Psychiatry and Neurology, General Psychiatry, #42609
American Board of Psychiatry and Neurology, Child and Adolescent Psychiatry,
#5101
2
Academic Appointments:
1992-1995
1995-1997
1997-
Clinical Fellow in Psychiatry, Harvard Medical School, Boston, MA
Clinical Fellow in Child Psychiatry, Harvard Medical School, Boston, MA
Instructor in Psychiatry, Harvard Medical School, Boston, MA
Hospital Appointments:
1991-1992
1992-1995
1993-1996
1994-1995
1995-1997
1995-1998
1996-1997
1997-1999
1997-1999
19972000200020022004
Intern, Department of Medicine, Emory University Hospitals, Atlanta, GA
Resident in Psychiatry, Massachusetts General Hospital, Boston, MA
Moonlighting in Adult Psychopharmacology Clinic, Chelsea MGH,
Chief Resident, Acute Psychiatry Service, Massachusetts General Hospital
Clinical Fellow in Child Psychiatry, Massachusetts General and McLean
Hospitals
Staff Psychiatrist, Correctional Healthcare Solutions, Essex County House of
Corrections, Middleton, MA
Staff in Child Psychiatry, North Shore Children’s Hospital, Salem, MA
Medical Director, Outpatient Mental Health and Pediatric Psychopharmacology
Clinics, North Shore Children’s Hospital, Salem, MA
Staff, Boston Emergency Services Team, Boston, MA
Staff, Child Psychiatry Clinic, Massachusetts General Hospital, Boston, MA
Director, Child and Adolescent Psychiatry, North Shore Medical Center, Salem,
MA
Assistant Psychiatrist, Massachusetts General Hospital
Associate Chief of Psychiatry, Salem Hospital, Salem, MA
Medical Director, Massachusetts Child Psychiatry Access Project, Salem, MA
Major Committee Assignments
200020002000-2001
2001- 2007
2002-2005
2002-2007
2002-2004
200320042004-
Children’s Mental Health Task Force, Massachusetts Chapter of the American
Academy of Pediatrics, Massachusetts Medical Society
Ethics Advisory Committee, North Shore Medical Center
Professional Advisory Board, WellChild Foundation, Blue Cross & Blue Shield of
Massachusetts
Committee on Continuing Medical Education, North Shore Medical Center
Professional Advisory Board, Children and Adults with Attention Deficit Disorder
(CHADD)
Committee on Pharmacy and Therapeutics, North Shore Medical Center
Editorial Advisory Board, Attention Magazine
Board of Directors, Children’s Trust Fund
Professional Advisory Board, Adult Attention Deficit Disorder Association
Ad Hoc Member Essex County Child Fatality Review Team
Honors and Awards:
1996
Laughlin Fellow of the American College of Psychiatrists
3
1996
Eli Lily Pilot Research Award for “Nortriptyline for Attention Deficit
Hyperactivity Disorder in Children and Adolescents”
Partners in Excellence Award for development and growth of Pediatric Mental
Health Clinic, North Shore Children’s Hospital
Best Doctors in America, Best of Boston
1998
2005
Memberships in Professional Societies:
198719922002-
American Medical Association
American Psychiatric Association
American Academy of Child and Adolescent Psychiatry
Reviewer for Scientific Journals (ad hoc):
1998200020012001200320032004200420062006
2006
Journal of the American Academy of Child and Adolescent Psychiatry
Harvard Review of Psychiatry
Expert Opinion on Investigational Drugs
Expert Opinion in Pharmacotherapy
CNS Drugs
Canadian Institutes of Health Research
Journal of Child and Adolescent Psychopharmacology
Journal of Developmental and Behavioral Pediatrics
Journal of Clinical Psychiatry
Comprehensive Psychiatry
Pediatrics
Research Experience:
1985-86
1993
1993
1994
1995
199519951995
1996
1996
Investigator, "Role of retinoic acid in the differentiation of embryonal carcinoma cells"
(Undergraduate Thesis)
Co-Principal Investigator, "Clonidine for ADHD-associated sleep disturbances: A
systematic review of 62 cases"
Investigator, "Efficacy of desipramine in adults with attention deficit hyperactivity
disorder"
Co-Principal Investigator, "Pocket-sized electronic referencing: a pilot study of physician
acceptance and usefulness"
Investigator, "Effectiveness and tolerability of tomoxetine in adults with attention deficit
hyperactivity disorder"
Investigator, “The clinical course of prepubertal mania: A systematic review of 70 cases”
Co-Principal Investigator, “Co-administration of stimulants with desipramine: Effect on
desipramine plasma levels”
Investigator, “Efficacy of magnesium pemoline in adolescents and adults with attention
deficit hyperactivity disorder”
Co-Principal Investigator, “A double blind discontinuation phase study of nortriptyline
for attention deficit hyperactivity disorder”
Investigator, “Safety and efficacy of depakote in acute mania in adolescents and
children”
4
1996
1996
1997
1997
1998
1998
1998
1998
1999
2000
2000
2000
2000
2000
2000
2000
2001
2001
2001
2002
2002
2003
2003
Investigator, “Assessment of autonomic nervous system activity controlling cardiac
function in the treatment of ADHD and other psychiatric disorders
Investigator, “ABT-418 vs. Placebo in Adults with ADHD”
Site Investigator, “A double blind placebo controlled trial of buspirone vs.
placebo in children”
Investigator, “Safety and pharmacokinetic study of tomoxetine hydrochloride in pediatric
ADHD”
Investigator, “Efficacy of olanzapine in juvenile bipolar disorder”
Site Investigator, “A double blind placebo controlled trial of venlafaxine XR in
adolescent depression”
Principal Investigator, “A double blind placebo controlled trial of bupropion SR for
ADHD in adults with bipolar disorder”
Investigator, “Tolerability and effectiveness of Oros Methylphenidate in pediatric
ADHD”
Co-Principal Investigator, “A open trial of bupropion SR for ADHD in adults with
substance use disorder”
Investigator, “A phase II, multicenter, randomized, double-blind, placebo-controlled
study of GT-2331 in adults with attention deficit hyperactivity disorder”
Investigator, “A double-blind placebo controlled study of the effectiveness of paroxetine
in the treatment of social phobia in children and adolescents”
Site-Investigator (North Shore Children’s Hospital) “A double-blind placebo controlled
trial of bupropion in the prevention of tobacco use in adolescents with ADHD followed
by an eight week open label extension”
Investigator, “A double-blind placebo-controlled simulated classroom study of modafinil
in children and adolescents with attention-defict/hyperactivity disorder
Investigator, “An open-label assessment of paroxetine in children and adolescents with
obsessive-compulsive disorder or major depression”
Investigator, “A phase III double-blind placebo-controlled trial of the safety and efficacy
of fixed doses of tomoxetine in children and adolescents with attentiondeficit/hyperactivity disorder”
Site-Investigator (North Shore Medical Center) “A double-blind placebo controlled trial
of fluoxetine vs. St John’s Wort in the treatment of major depression in adults”
Investigator, “A four week open-label pharmacokinetic study of modafinil in children
with ADHD”
Investigator, “Study of the pharmacokinetics of paroxetine in children and adolescents”
Investigator, “Study of the pharmacokinetics of olanzapine in children and adolescents”
Investigator, “Open-Label Comparative Study of Risperidone versus Olanzapine For
Mania in Preschool Children 4 to 6 Years of Age with Bipolar I or Bipolar II Disorder”
Investigator, “Open-Label Study of Ziprasidone for the Treatment of Mania in Children
and Adolescents with Bipolar I and Bipolar II Disorder”
Investigator, “A Randomized, Double-Blind Placebo-Controlled Study of Atomoxetine
Hydrochloride in Adolescents with Attention Deficit/Hyperactivity Disorder and
Comorbid Depressive Disorder”
Investigator, “A Randomized, Double-Blind Placebo-Controlled Study of Atomoxetine
Hydrochloride in Children and Adolescents with Attention Deficit/Hyperactivity Disorder
and Comorbid Anxiety”
5
2003
2003
2003
Investigator, “A Phase III, Randomized, Double-Blind, Parallel-Group, PlaceboControlled Safety and Efficacy Study of Adderall XR in Children and Adolescents Aged
6-17 with Oppositional Defiant Disorder”
Investigator, “Open-Label Comparative Study of Concerta versus Adderall in the
Treatment of ADHD in Youth and Adults with Bipolar I and Bipolar II Disorder”
Investigator, “Open-Label Study of Concerta in the Treatment of ADHD in Youth
and Adults with Bipolar I, Bipolar II and Bipolar Spectrum Disorder”
Major Research Interests:
1.
2.
3.
4.
Characterization of attention deficit hyperactivity disorder in children, adolescents, and adults.
Characterization of depressive, bipolar, anxiety and substance use disorders in children and
adolescents
Delivery of psychiatric services in health care systems
Medical ethics
Teaching Experience:
Lecturer to Medical Students and Residents:
1994-
Lecturer (medical students), core curriculum in Psychiatry, Department of Psychiatry,
Massachusetts General Hospital, Harvard Medical School
1994Lecturer (residents), core clinical curriculum in Psychiatry, Department of Psychiatry,
Massachusetts General Hospital, Harvard Medical School
1997Lecturer (child psychiatry fellows), core clinical curriculum in Psychiatry, Department of
Psychiatry, Massachusetts General Hospital, Harvard Medical School
1998
Lecturer (Psychology Interns), core curriculum in Psychology, North Shore Medical
Center
Supervision:
199419971997-
Clinical Supervisor, Acute Psychiatry Service, Massachusetts General Hospital and
Harvard Medical School
Supervisor, Child and Adult Psychiatry Service, Massachusetts General Hospital and
Harvard Medical School
Clinical Supervisor, North Shore Medical Center
Academic Presentations
1994
1994
1995
1995
Academic Conference: "Attention Deficit Disorder in Adults: Should We Pay Attention?”
Massachusetts General Hospital, Harvard Medical School, Boston, MA
Academic Conference: "Attention Deficit Hyperactivity Disorder: Neurobiology and
Treatments", Massachusetts General Hospital, Harvard Medical School, Boston, MA
Pediatric Grand Rounds “Attention Deficit Hyperactivity Disorder in Children and
Adolescents”, North Shore Children’s Hospital, Salem, MA
“Stress and Its Effects on Residents”, Massachusetts General Hospital, Boston, MA
6
1995
1996
1997
1998
1998
1998
1998
1998
1998
1998
1999
1999
1999
1999
1999
1999
1999
1999
1999
1999
Academic Presentation to Annual Review of Pediatric Conference for Continuing
Medical Education, “Attention Deficit Hyperactivity Disorder Through the Lifespan”,
Lake George, NY
Symposia: Does juvenile bipolar disorder exist? New research and findings: Parts I and
II. Symposia for American Academy of Child and Adolescent Psychiatry, Philadelphia,
PA 1996 12: 70-71.
Symposia for Brain Awareness Week sponsored by Harvard Medical School at The
Museum of Science, “Attention Deficit Hyperactivity Disorder”, Boston, MA
Psychiatry Grand Rounds, " Attention Deficit Hyperactivity Disorder in Adults”,
Emerson Hospital, Concord, MA
Pediatric Grand Rounds, “Mood Disorders in Children and Adolescents”, North Shore
Children’s Hospital, Salem, MA
Psychopharmacology Course for Continuing Medical Education, “Mood Disorders
in Children & Adolescents”, Massachusetts General Hospital, Boston, MA
National Alliance for the Mentally Ill of Oklahoma, “Survey of Childhood
Psychopathology” and “Childhood Depression”, Annual Meeting, Tulsa, Oklahoma
Academic Presentation, “Pharmacological Treatment of Anxiety Disorders in Children
and Adolescents”, North Shore Medical Center, Salem, MA
Academic Presentation to Alliance for the Mentally Ill of Erie County, “Attention
Deficit Hyperactivity Disorder and Mania in Children and Adolescents”, Erie County, PA
Pediatric Grand Rounds, “Treatment of Bipolar Disorder in Children and Adolescents”,
North Shore Children’s Hospital, Salem, MA
Academic Presentation to Massachusetts Society of Neuropsychology, “Recent Advances
in Pharmacotherapy”, Spalding Rehabilitation Hospital, Boston, MA
Pediatric Grand Rounds, “Recent Advances in the Treatment of Anxiety and Depression
in Children and Adolescents”, Beverly Hospital, Beverly MA
Psychiatric Grand Rounds, “Recent Advances in the Treatment of Attention Deficit
Hyperactivity Disorder”, University of Connecticut, Farmington, CT
Pediatric Grand Rounds, “Cardiovascular side effects of psychotropic medications used
in Children and Adolescents” given with Barry Ticho, M.D. from Pediatric Cardiology
Massachusetts General Hospital, North Shore Children’s Hospital, Salem, MA
Consulting Rounds, Lynn Community Health Center “Review of Psychotropic
Medications Used in Children & Adolescents”, Community Health Center, Lynn, MA
Annual Nursing Forum, “Diagnosis and treatment of Anxiety Disorders in
Children and Adolescents”, North Shore Medical Center, Salem, MA
Advances in Identification and Treatment of Childhood Behavioral Disorders: “Why
children misbehave: a neurological, developmental, and physiological perspective” and
“The psychopharmacologic management of children with disruptive behavior”, Colby
College and Maine General Medical Center, Waterville, Maine
Current issues for special education administrators “What to expect and not expect from
psychotropic medications used in children and adolescents”, Landmark School, Prides
Crossing, MA
Kaiser Permanente Second Annual ADHD Conference: ADHD through the lifespan:
integrated treatment in managed care settings “Psychopharmacology: using the
stimulants” & “Psychopharmacology: refractory cases”, Vail, Colorado
“Educational Challenges for the New Millennium”, Academic Presentations on
“Attention Deficit Hyperactivity Disorder” & “Adolescent Depression”, Marblehead, MA
7
1999
1999
1999
1999
1999
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
Zarrow Mental Health Symposium, “Today’s Adolescents, Tomorrow’s Adults: Planning
to Prevent Youth Violence and Self-destructive Behavior” “The Clinical Presentation,
Diagnosis, and Treatment of Depression in Children and Adolescents”, Tulsa, Oklahoma
Montana State Conference on Mental Illness: “Recovery Into The Future” “Attention
Deficit Hyperactivity Disorder Through The Lifespan” and “Recognition and Treatment
of Juvenile Mood Disorders”, Great Falls, Montana
Psychopharmacology Course for Continuing Medical Education, “Juvenile Mood
Disorders” Massachusetts General Hospital, Boston, MA
A controlled trial of nortriptyline for ADHD. In New Research in the treatment of ADHD
Scientific presentation at the Annual Meeting of the American Academy of Child and
Adolescent Psychiatry, Chicago, Ill; S-42E, October 1999.
Academic Presentation “A Long Strange Trip: Adolescents Discuss Their Own World”
as part of “The Alienated Child” Conference sponsored by North Shore Medical Center,
Salem, MA
Continuing Training, Full Day Symposia on “Update & Overview of Psychiatric
Medications Used in Children and Adolescents” to Department of Social Services,
Boston, MA
Continuing Medical Education for School Nurses“An Update and Overview of
Psychiatric Medications Used in Children and Adolescents” ,Salem Hospital, Salem, MA
Keynote address, Attention Deficit Disorders Association, Southern Region, “ADD2000:
A Comprehensive Approach” “Update on the Neurobiology of ADD”; “Bipolar Disorder
in Adolescents”; “Recent Advances in the Pharmacotherapy of ADD” Irving, Texas
Child and Adolescent Psychopharmacology, Moderator, “Panel: Ask the Experts” for
Continuing Medical Education, Massachusetts General Hospital, Boston, MA
Child Psychopharmacology State-of-the-Art-Therapies for Continuing Medical
Education, “Pharmacotherapy of Anger & Aggression in Children & Adolescents”
McLean Hospital, Belmont, MA
18th Annual Conference of The Learning Disabilities Network “Unlocking Learning
Potential”. “An Update & Overview of Psychotropic Meds Used in Children &
Adolescents” Randolph, MA
International College of Psychiatric and Neurologic Pharmacists Annual Meeting:
Looking to the Future, “ Non-Stimulant Pharmacotherapies of ADHD” Washington, DC
Misseldine Lecture for the Annual Joint Meeting of the Council of Child and Adolescent
Psychiatrists and the Psychiatric Society of Central Ohio “An Overview and Update on
ADHD Through the Lifespan” Columbus, Ohio
A Practical Update on ADHD for Continuing Medical Education “Lifespan Perspective
of ADHD: Treatment with Stimulant and Non-Stimulant Medications” MGH Grand
Hotel Las Vegas, Nevada
Joint Meeting of the Pediatric Academic Society and The American Academy of
Pediatrics Year 2000 Joint Meeting. Advances and Application of Psychopharmacology
in Pediatrics “Attention Deficit/Hyperactivity Disorder” Boston, MA
Psychopharmacology Course for Continuing Medical Education, “Psychotic Disorders in
Childhood” “Attention Deficit Hyperactivity Disorder Through the Lifespan”
Massachusetts General Hospital, Boston, MA
Handle with Care: The Art & Science of Helping People Who Struggle with Differences
in Attention and Learning “Understanding the Current Conceptualization of ADHD and
8
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2001
2001
2001
2001
Comorbid Conditions as Neurobehavioral Disorders” and “Current Medical Diagnostic
Techniques: Brain Imaging” Hyannis, MA
153rd Annual Meeting of the American Psychiatric Association. Evidence Based
Management of Refractory Depression “Juvenile Depression: Diagnosis and Treatment”
Chicago, Illinois
Hospital Angeles de las Lomas. “Pharmacotherapy of ADHD Through the Lifespan”,
Mexico City, Mexico
Psychiatry and Neurology Grand Rounds. “Recent Developments in the Genetics and
Neurobiology of ADHD” and “Pharmacotherapy of ADHD Across the Lifespan”,”
Hospital ABC, Mexico City, Mexico
Pediatric Grand Rounds, Baystate Medical Center, “Recent Advances in the
Neurobiology and Treatment of ADHD” Springfield, MA
Massachusetts Continuing Legal Education Conference on Juvenile Law “Medicating
Children: Child and Adolescent Psychopharmacology” Boston, MA
12th Annual Children and Adults with Attention-Deficit/Hyperactivity Disorder
(CHAAD) International Conference; Symposiums “ Depression and Bipolar Disorder
within ADHD” “Substance Use Disorders and ADHD” “Pharmacotherapy of ADHD and
Comorbid Conditions” “Pharmacotherapy of ADHD for Pediatricians” Chicago, Illinois
Annual Meeting of the Northeast Regional Klienfelter’s Association “Issues related to the
treatment of ADHD and other psychiatric disorders in children and adolescents with
Kleinfelter’s syndrome” Burlington, MA
American International College, “What You Need to Know About the Medications
Prescribed for Common Psychiatric Disorders in Children and Adolescents from ADHD
to Mood Disorders” Springfield, MA
National Association for Continuing Education “The Hidden Disorders: Juvenile
Depression and Mania” Torrance, California
Wellchild, the University of Massachusetts Medical School and the Massachusetts
Chapter of the American Academy of Pediatrics, “Too Young for ADHD? The Wellchild
Conference on Early Childhood Identification, Labeling, & Treatment” Boston, MA
20th Anniversary Boston National Primary Care Conference, Nurse Practitioner
Associates for Continuing Education, “Psychopharmacology in Children: What We Need
to Know” Boston, MA
Bad, Mad or Sad? “An Update on the Co morbidity of ADHD and Substance Use
Disorders; Recent Advances in Juvenile Bipolar Disorder; Treatment of Juvenile Bipolar
Disorder” Providence Alaska Medical Center, Anchorage, AK
Psychiatric Grand Rounds “Mad, Bad or Sad? Juvenile Mood Disorders” McLean
Hospital, Belmont, MA
Cambridge Hospital Series Understanding the Brain: Tools for Clinicians Treating
Children “Psychopharmacologic and Psychiatric Interventions” Boston, MA
Maine Psychiatric Association’s Annual Winter Meeting “Attention Deficit Hyperactivity
Disorder in Adults” Portland, ME
National Association for Continuing Education, “Pharmacotherapy of ADHD with
Stimulants and Non-stimulants” Sacramento, CA
19th Annual Learning Disabilities Network “An Update on Psychiatric Medications Used
in Children and Adolescents” Randolph, MA
9
2001
2001
2001
2001
2001
2001
2001
2001
2001
2001
2001
2001
2001
2002
2002
2002
2002
2002
2002
2002
National Attention Deficit Disorder Association Conference “One Year Safety of
Concerta in Children with ADHD” and “Pharmacotherapy of ADHD and Mood
Disorders” Seattle, WA
Massachusetts Chapter of the American Academy of Pediatrics “ADHD and Beyond: An
Update on Childhood Mental Health Issues” Waltham, MA
Continuing Medical Education Course for Massachusetts General Hospital/Harvard
Medical School “Major Psychiatric Illness in Children and Adolescents”
“Pharmacotherapy of Depressive and Bipolar Disorders in Children and Adolescents”
Boston, MA
Medical Grand Rounds, “Attention Deficit Hyperactivity Disorder Through the Lifespan” Southern New Hampshire Medical Center, Nashua, NH
Committee for Public Counsel Services Children and Family Law Program Rogers
Training “An Overview and Update on Psychotropic Medications Used in Children and
Adolescents” Andover, MA
Child and Adolescent Psychiatrists of Central Ohio Conference “Overlap of ADHD and
Bipolar Disorders: Recognition, Diagnosis, and Pharmacotherapy” Columbus, OH
Connecticut Association of Physician Assistants Charter Oak Conference “Attention
Deficit Hyperactivity Disorder Through the Life-span” Westbrook, CT
2nd Annual National Meeting of the American Association for Klinefelter Syndrome
Information and Support; “Neurological Issues of 47XXY” Philadelphia, PA
33rd Annual Conference of the Arizona Association of School Psychologists,
“Pharmacotherapy of ADHD with Stimulant and Non-Stimulant Medications” Mesa, AZ
14th Annual CHADD International Conference, “AD/HD and Depression” and “AD/HD
and Bipolar Disorder”, Anaheim, CA
Annual Meeting of the American Academy of Pediatrics, “ADHD Through the Lifecycle”
San Francisco, CA
Psychiatric Grand Rounds, Beth Israel Medical Center, “The Overlap of ADHD and
Depression”, New York City, NY
Primary Care Pediatrics Conference “Psychotropic Medications in Pediatric Practice”
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Psychiatry Grand Rounds, “Controversies in the Diagnosis of Bipolar Disorder in
Children and Adolescents”, BayState Medical Center, Springfield, MA
Continuing Legal Education, Mental Health Legal Advocacy Committee, “Truth, Myth
and Misconceptions in Pediatric Psychopharmacology” Federal Reserve Bank, Boston,
MA
Medical Grand Rounds, “Mad, Sad or Bad: Recognition and Treatment of Mood
Disorders in Adolescents”, Saints Memorial Medical Center, Lowell, MA
Pediatric Grand Rounds, “Diagnosis and Treatment of Depression in Pediatric Office
Practice”, North Shore Children’s Hospital, Salem, MA
Pediatric Grand Rounds, “New Developments in the Treatment of ADHD in Children and
Adolescents”, Miami Children’s Hospital, Miami, FL
Pediatric Conferences, “Assessment and Pharmacotherapy of ADHD in Children and
Adolescents”, Methodist and Riley Children’s Hospitals, Indiana School of Medicine,
Indianapolis, IN
Psychiatric Grand Rounds, “Advances in ADHD Across the Life-span”, Riley Children’s
Hospital, Indiana School of Medicine, Indianapolis, IN
10
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2003
2003
2003
2003
Academic Symposia, Pharmacotherapy of ADHD with stimulant and non-stimulant
medications”, University of Stirling, Stirling, Scotland
Psychology Colloquium, “Finding comfort: Treating post-traumatic stress disorder in
children and adolescents” Salem State College, Salem, MA
Pediatric Conference, “Diagnosis and Treatment of Comorbid Conditions Associated
with ADHD” Bellin Health Systems, Green Bay, WI
Pediatric Conference, Pediatric Office Management, “Pediatric Primer in Evaluation and
Treatment of Behavior Disorders” with James Perrin, M.D., North Shore Medical Center,
Salem, MA
20th Annual Learning Disabilities Network Conference, “Use of Psychiatric Medications
in Children and Adolescents”, Randolph, MA
155th Annual Meeting of the American Psychiatric Association “Advanced Assessment
and Treatment of ADD” and “ADD in Children and Adolescents” with Thomas Brown,
Ph.D. Philadelphia, PA
Psychiatric Grand Rounds, “Diagnosis and Treatment of Juvenile Bipolar Disorders”
Franciscan Children’s Hospital, Brighton, MA
International Conference on ADHD “Steps to Success.” “Pharmacologic Treatment of
ADHD and Related Disorders in Children, Adolescents and Adults” and “Medical
Management of ADHD and Related Disorders.” Sydney, Australia
Psychiatric Grand Rounds, “Differentiating ADHD from Bipolar Disorder” Union
Hospital, Lynn, MA
Meeting of Council of South Florida Child Psychiatrists, “Update on Pharmacotherapy of
ADHD”, Miami, FL
15th Annual Children and Adults with ADD International Conference, “Treatment of
AD/HD and Mood Disorders” and “Pharmacotherapy of Adults with AD/HD”, Miami,
FL
18th Annual Learning Differences Conference, “Attention Deficit Disorders: What’s new
in our methods of diagnosis and treatment” Harvard Graduate School of Education and
Research Institute for Learning and Development, Cambridge, MA
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, “Psychopharamcology of Aggressive, Resistant, and Delinquent Youth”, Boston,
MA
Keynote Speaker Conference Sponsored by Maine Medical Center, “Attention Deficit
Hyperactivity Disorder: Impact, Assessment, Diagnosis, Comorbidity and
Pharmacotherapy” Augusta, ME
Pediatric Mental Health in Primary Care Practice. “Update on New Treatments for
ADHD” and Diagnosis and Treatment of Depression” Partners Psychiatry and Mental
Health, Massachusetts Medical Society, Waltham, MA
Neurodevelopmental Disorders in Children “Risk and Benefits of Psychiatric Medications
in Children with Neurodevelopmental Disorders” sponsored by The Cambridge Hospital
Department of Psychiatry, Boston, MA
Keynote address, Attention Deficit Disorders Association, Southern Region, “Update on
Recent Developments in the Pharmacotherapy of ADHD” “Pharmacotherapy of ADHD
and Comorbid Disorders” “History of ADHD: The First Hundred Years” Houston, Texas
Continuing Medical Education sponsored by South Eastern Massachusetts Psychiatric
Society “Differentiating Bipolar Disorder and Attention Deficit/Hyperactivity Disorder in
Children, Adolescents and Adults” Cape Cod Hospital, Hyannis, MA
11
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
2003
Charter Oak Conference sponsored by Connecticut Academy of Physician Assistants,
“ADHD in Children and Adults” Newport, RI
American Academy of Pediatrics, District I and V Meeting, “Mental Health Crisis in
Pediatrics” Chicago, Ill
National Conference of State Legislators, “Crisis in Adolescent Health: Use of
Psychiatric Medications in Youth” Boston, MA
National Attention Deficit Disorder Association Conference “Assessment and Treatment
of ADHD and Associated Comorbidities” Portsmouth, VA
156th Annual Meeting of the American Psychiatric Association “ADD in Adults” “ADD
in Children and Adolescents” and “Advanced Assessment and Treatment of ADD” with
Thomas E. Brown, Ph.D. San Francisco, CA
Pediatric Grand Rounds, “Evaluation and Treatment of Depression in Pediatric Office
Practice” Lowell General Hospital, Lowell, MA
Psychiatry Grand Rounds, “ Clinical Implications of Comorbidity in the Pharmacotherapy
of ADHD” Franciscan’s Children’s’ Hospital, Brighton, MA
135th Annual Meeting of the Mississippi State Medical Association “Attention Deficit
Hyperactivity Disorder Through the Lifespan” Biloxi, MS
Mental Health Legal Advisors Committee “Mood and Anxiety Disorders in the
Courtroom: Special Issues for Bipolar Children and Adolescents” with Gary Sachs, M.D.,
Suffolk University Law School, Boston, MA
Pediatric Grand Rounds “Assessment and Treatment of ADHD and Comorbid
Conditions” Temple University Hospital, Philadelphia, PA
65th Annual Meeting of the College on Problems of Drug Dependence, “Efficacy and
Tolerability of Bupropion SR for ADHD in Adults with Substance Use Disorders”
Miami, FL
Psychiatry Grand Rounds, “ADHD in Adults” North Shore Medical Center, Salem, MA
4th Annual National Meeting of the American Association for Klinefelter Syndrome
Information and Support; “ADHD in the Child with Klinefelter’s Syndrome” Chicago, IL
Keynote Speaker, Advances in Identification and Treatment of Childhood Behavioral
Disorders: “Pharmacotherapy of ADHD Through the Lifespan” “Diagnosis and
Treatment of Pediatric Bipolar Disorder” “ADHD and Comorbid Psychiatric Disorders”,
Colby College and Maine General Medical Center, Waterville, Maine
National Association of Continuing Education “Stimulant and Nonstimulant
Pharmacotherpay of ADHD” Jacksonville, FL
Pediatric Grand Rounds, “Recent Developments in the Neurobiology of ADHD:
Genetics, Neuroimaging and Pharmacodynamics of Stimulant Medications” Albert
Einstein Hospital, Philadelphia, PA
Psychiatry Grand Rounds, “Overview and Update on Attention Deficit/Hyperactivity
Disorder Through the Lifespan” Acadia Hospital, Bangor, ME
National Football League, Substance Abuse Treating Clinicians Conference “Attention
Deficit Hyperactivity Disorder and Substance Use Disorders: Identification, Diagnosis
and Treatment” Houston, TX
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Pediatric Neurology “Attention Deficit Hyperactivity Disorder”
Boston, MA
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Psychiatry “ADHD Across the Lifespan” Boston, MA
12
2003
2003
2003
2003
2003
2003
2003
2003
2004
2004
2004
2004
2004
2004
2004
2004
2004
2004
2004
2004
Medical Grand Rounds, St Mary’s Hospital “ADHD in Adolescents and Adults”
Lewiston, ME
Psychiatry Grand Rounds, Four Winds Hospital “Update on Neurobiology and
Pharmacotherapy of ADHD” Saratoga Springs, NY
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Pediatrics “Pharmacotherapy of ADHD” and “Evaluation and
Treatment of Depression and Anxiety in Children and Adolescents” Boston, MA
16th Annual Children and Adults with ADD International Conference, “AD/HD and
Mood Disorders Through the Lifespan” Denver, CO
Pediatric Mental Health in Primary Care Practice “Diagnosis and Treatment of Pediatric
Depression” Partners Psychiatry and Mental Health, Massachusetts Medical Society,
Waltham, MA
National Association for Continuing Education, “Pharmacotherapy of ADHD with
Stimulants and Non-stimulants” Birmingham, AL
Pediatric Grand Rounds, Mercy Children’s Hospital “Neurobiology and Pharmacotherapy
of ADHD” Kansas City, MO
Pediatric Grand Rounds, University of Kansas Medical Center “Genetics, Neurobiology
and Pharmacotherapy of ADHD” Kansas City, KS
Psychiatric Grand Rounds, University of Alabama Birmingham Medical School “ADHD
and Mood Disorders” Birmingham, AL
Pediatric Grand Rounds, Cook’s Children Hospital “ADHD and Substance Use
Disorders” Fort Worth, TX
Psychiatric Grand Rounds, Emory University School of Medicine “Pediatric Bipolar
Disorders: Comorbidity with ADHD and Substance Use Disorders” Atlanta, GA
13th Annual Masters of Pediatrics Conference, sponsored by the University of Miami
School of Medicine “Evaluation and Diagnosis of ADHD” “Pharmacotherapy of ADHD”
“ADHD and Substance Use Disorders” Miami, FL
Child Psychiatry Grand Rounds, Denver’s Children’s Hospital “ADHD and Comorbid
Disorders: Implications for Pharmacotherapy” Denver, CO
Symposium Medicus, “Update on Pharmacotherapy of ADHD with Stimulants and Nonstimulants” “Mad, Bad or Sad: Pediatric Bipolar Disorder” “Office Management of
Pediatric Depression” Big Sky, MT
25th Annual Conference of The National Association of Pediatric Nurse Practitioners,
“Update on the Science and Diagnosis of ADHD” Dallas, TX
157th Annual Meeting of the American Psychiatric Association “ADD in Adults” “ADD
in Children and Adolescents” and “Advanced Assessment and Treatment of ADD” with
Thomas E. Brown, Ph.D. New York City, NY
157th Annual Meeting of the American Psychiatric Association “Clinical Presentation of
ADHD in Adults” with Timothy Wilens, M.D. New York City, NY
1st Annual Psychopharmacology Update sponsored by Duke Medical Center
“Pharmacotherapy of ADHD” Key Biscayne, FL
Pediatric Grand Rounds, Beverly Hospital “Managing Pediatric Anxiety and Depression:
Concerns of Treatment” Beverly, MA
Learning and the Brain Conference sponsored by Massachusetts Institute of Technology,
“New Developments in the Diagnosis and Treatment of ADHD” Cambridge, MA
13
2004
2004
2004
2004
2004
2004
2004
2004
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
Pediatric Adolescent Health Conference sponsored by Scott & White Hospital and Texas
Tech University “Adolescent Depression and Drug Therapy” and “ADD, ADHD and
Adolescents” San Antonio, TX
Continuing Medical Education sponsored by PriMed “Managing the Patient with
Attention Deficit Hyperactivity Disorder Beyond Childhood” Brooklyn, NY
Psychiatric Grand Rounds, North Shore Medical Center “Antidepressants and Adolescent
Suicide” Salem, MA
33rd Annual Meeting of the Child Neurology Society “Developmental
Psychopharmacology: Newer Medications and Therapeutic Approaches” Ottawa, Canada
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Psychiatry “Pediatric Psychosis” Boston, MA
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Pediatrics, Primary Care Conference “Safety and
Recommendations for Using Psychiatric Medications in Children and Adolescents"
Cambridge, MA
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Pediatrics “Pharmacotherapy of ADHD” and “Recommendations
for Using and Monitoring Psychiatric Medications in Pediatric Patients” Boston, MA
Pediatric Grand Rounds, Beverly Hospital “Adolescent Depression and Suicide” Beverly,
MA
Learning and the Brain Conference sponsored by Massachusetts Institute of Technology,
“Pharmacotherapy of ADHD” Cambridge, MA
14th Annual Masters of Pediatrics Conference, sponsored by the University of Miami
School of Medicine “Evaluation and Diagnosis of Comorbidity within ADHD”
“Pharmacotherapy of ADHD” “Neurobiology of ADHD ” Miami, FL
Continuing Medical Education Conference Adolescent Self Destruction sponsored by the
Cambridge Hospital and Harvard Medical School “Using Psychiatric Medications: Do
They Cause or Prevent Suicide” Boston, MA
Psychiatry Grand Rounds, Hospital For Sick Children “Update on Using Antidepressants
in Children & Adolescents: Update on Risk of Suicide” Toronto, Canada
Psychiatric Grand Rounds North Shore Medical Center “Update and Review of
Assessment of Suicidal Patients” Salem, MA
National Association of Pediatric Nurse Practitioners Annual Meeting “Science,
Evolution and Diagnosis of ADHD” Phoenix, AZ
36th Annual Medical-Scientific Conference American Society of Addiction
Medicine/National Institute of Drug Abuse “Risks for Addiction Among Adolescents
Treated with Prescription Stimulants” Dallas, TX
Developmental-Behavioral Pediatric Conference Sponsored by Boston University School
of Medicine “Office Recognition and Management of Depressed Children: Should We Be
Prescribing the SSRIs?” Cambridge, MA
Pediatric Mental Health Conference sponsored by Partners Psychiatry and Mental Health
“Depression and the SSRI Controversy” Newton Wellesley Hospital Newton, MA
Florida Psychiatric Society Spring Meeting “Antidepressants and Suicidality: Clinical
Considerations” Clearwater Beach, FLA
Massachusetts Chapter of the American Academy of Pediatrics, “Updates in Pediatrics:
Office Management of Pediatric Depression” Waltham, MA
14
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2006
2006
Continuing Education Program for Pharmacists sponsored by American Health Resources
“Neurobiology and Pharmacotherapy of ADHD” Westford, MA
American Psychological Association Annual Meeting Symposium “Recent research on
ADHD in Adults: Pharmacotherapy of ADHD in Adults” Washington, DC
158th Annual Meeting of the American Psychiatric Association “ADD in Adults” “ADD
in Children and Adolescents” and “Advanced Assessment and Treatment of ADD” with
Thomas E. Brown, Ph.D. Atlanta, GA
Saudi Arabia Medical Services Organization Massachusetts General Hospital “Adult
ADD” Boston, MA
American Academy of Pediatrics 75th National Conference and Exhibition Section on
Adolescent Health “Oppositional Defiant Disorder and Conduct Disorder in Children and
Adolescents” Washington, DC
22nd Annual Current Advances in Pediatrics sponsored by the California Chapter 4 of the
American Academy of Pediatrics “”Managing Pediatric Anxiety and Depression”
“Update on the Neurobiology and Pharmacotherapy of ADHD” “”Risks and Benefits of
Treatment for Child and Adolescent Mental Disorders” “Pediatric Bipolar Disease and
Related Conditions” Irving, CA
Department of Psychiatry University of South Dakota School of Medicine “Neurobiology
of ADHD” and “Pharmacotherapy of ADHD and Comorbid Psychiatric Conditions”
Sioux Falls, SD
Juvenile Court Department of the Commonwealth of Massachusetts Annual Spring
Judges Conference “What Mental Illness Looks Like in Children: Bipolar, Depressive
and Anxiety Disorders” Lenox, MA
Topics in Primary Care sponsored by the Massachusetts General Hospital for
Children/Harvard Medical School Department of Continuing Education “ADHD”
Cambridge, MA
Continuing Education for Pharmacists sponsored by American Health Resources, Inc.
“Understanding ADHD: New enhanced Treatment Regimens” Westford, MA
Harvard Medical School Department of Continuing Education and Cambridge Hospital
Autism Spectrum Disorders: From Childhood to Adulthood “Psychopharmacology of
Autism Across the Lifespan” Boston, MA
Continuing Medical Education for Harvard Medical School/Massachusetts General
Hospital Department of Neurology “Neurobiology and Pharmacotherapy of ADHD”
Cambridge, MA
American Psychiatric Association Online Grand Rounds “Suicide Assessment” with
Douglas Jacobs, M.D.
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Psychiatry “Psychotic Disorders in Children and Adolescents
Boston, MA
Primary Care Pediatrics Conference sponsored by the Massachusetts General Hospital for
Children/Harvard Medical School “Safety and Recommendations for Using Psychiatric
Medications in Children” and “Pharmacotherapy of ADHD”
Grand Rounds Medical/Pediatric Residency “Treatment of Pediatric Depression”
Massachusetts General Hospital, Boston, MA
Pediatric Grand Rounds, “Pharmacotherapy of ADHD and Update on Cardiovascular
Effects of ADHD Treatments” Caritas Holy Family Hospital Methuen, MA
15
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
Developmental and Behavioral Pediatrics Conference sponsored by Boston University
School of Medicine “Meds and ADHD: A State-of-the Art-Update” Boston, MA
National Association of Pediatric Nurse Practitioners Annual Meeting “Science, Update
on Assessment and Diagnosis of ADHD” Washington, DC
National Organization of Social Security Claimants’ Representatives, Annual Spring
Conference “ADHD, Depression and Bipolar Disorders in Children” Boston, MA
17th Annual Meeting Advances in Pediatrics sponsored by The American Academy of
Pediatrics, California Chapter 2 “Assessment and Treatment of Pediatric Anxiety
Disorders” “Office Assessment and Diagnosis of Pediatric Depression”
“Pharmacotherapy of ADHD” “Risks and Benefits of Psychiatric Medications” Las
Vegas, NV
2nd Annual Conference of New England Pharmacists “Update on Pharmacotherapy of
ADHD” Ledyard, CT
Continuing Medical Education sponsored by Partners HealthCare for Patners’ Day
“ADHD Across the Lifespan” with Eugene Beresin, M.D. Boston, MA
14th Annual Learning and the Brain Conference sponsored by Massachusetts Institute of
Technology “ADHD: A Review and New Pharmacologic Treatments” Cambridge, MA
Psychiatric Conference Emerging Developments in Juvenile Bipolar Disorder sponsored
by the New England Council of Child and Adolescent Psychiatry “Differentiating ADHD
and Bipolar Disorder” Waltham, MA
Continuing Education Program for Pharmacists sponsored by American Health
Resources, Inc. “Understanding ADHD: Improving Patient Care” Nashua, NH
159th Annual Meeting of the American Psychiatric Association “ADD in Adults” “ADD
in Children and Adolescents” and “Advanced Assessment and Treatment of ADD” with
Thomas E. Brown, Ph.D. Toronto, Ontario
Legal Conference sponsored by the Mental Health Legal Advisors Committee,
Commonwealth of Massachusetts, Supreme Judicial Court “Mental Health Medications
for Children” at Massachusetts Continuing Legal Education Boston, MA
Continuing Medical Education for Massachusetts General Hospital/Harvard Medical
School, Department of Psychiatry “Practical Issues in Child Psychopharmacology Boston,
MA
Society of Adolescent Medicine New England Chapter, “Update on Pharmacotherapy of
ADHD” Boxborough, MA
18th International CHADD Conference on Attention Deficit/Hyperactivity Disorder
Keynote Address “Bridging the Gap: Bring The Science to the Patient” and “An Update
on Medication Treatment Across the Lifespan” Chicago, IL
16th Annual Pediatric Symposium sponsored by the Joe DiMaggio Children’s Hospital
“Recognition and Treatment of Pediatric Anxiety Disorders” “An Update on ADHD”
“Recognition, Assessment, Diagnosis and Treatment of Pediatric Depression in Your
Office” Hollywood, FL
53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry
Symposium on Practical Pediatric Psychopharmacology for Primary Care Clinicians
“Management of Pediatric Depression in a Primary Care Setting” San Diego, CA
76th National Conference and Exhibition of the American Academy of Pediatrics Section
on Adolescent Health “Advance in Pharmacotherapy of ADHD and Medication Side
Effects” and “Mental Health for the Pediatrician: An Office Based Plan for Treating
Depression” with Jeffrey Q. Bostic, M.D. Atlanta, GA
16
2006
Psychiatric Update Sponsored by the University of Wisconsin School of Medicine and
Public Health and Madison Institute of Medicine, Inc. “Attention-Deficit/Hyperactivity
Disorder in Adults” Madison, WI
2006
Primary Care Pediatrics Conference sponsored by the Massachusetts General
Hospital for Children/Harvard Medical School “Office Recognition, Assessment,
Diagnosis and Treatment of Anxiety and Depression in Children and
Adolescents” and “Assessment and Treatment of ADHD in the Adolescent”
2007
Continuing Medical Education Series “Assessment in Treatment of ADHD” sponsored by
the Read Family Trust North Shore Medical Center Salem, MA
2007
16th Annual Masters of Pediatrics Conference, sponsored by the University of Miami
School of Medicine “Challenging Cases Diagnosising and Treating ADHD”
“Pharmacotherapy of ADHD” “Neurobiology of ADHD ” Miami, FL
2007
National Association of Pediatric Nurse Practitioners Annual Meeting “Facing Diagnostic
and Treatment Challenges: Where do Adolescents and Young Adults with ADHD Fit
In?” Orlando, FL
2007
29th Annual Conference The Spectrum of Developmental Disabilities “ADHD- Beyond
The Basics” sponsored by Johns Hopkins University School of Medicine “Update on The
Pharmacotherapy of ADHD 2007” Baltimore, MD
Non-Academic Presentations
1994
1995
1996
1997
1998
1999
1999
2000
2000
2000
2000
2000
CHADD Parent Support Group: "Relationship of Anxiety, Depression, and ADHD",
Plymouth, MA
South Shore ADD Parent Support Group: “Attention Deficit Hyperactivity Disorder
Through the Life-span”, Cohasset, MA
Employee Assistance Program Series on Parenting, “Some Considerations on Parenting
Children with Attention Deficit Hyperactivity Disorder”, Massachusetts General
Hospital, Boston, MA
ADD-IN Parent Support Group: "ADHD and Mania in Children and Adolescents"
Plymouth, MA
Parent Support Group of Salem, “Review of Psychotropic Medications Used in Children
and Adolescents”, Salem, MA
Presentation to Regular and Special Education Departments of Hamilton-Wenham and
Manchester-by-the-Sea, “Review of Psychotropic Medications used in Children &
Adolescents”, Hamilton, MA
Special Education Department “Review of Psychotropic Medications used in Children &
Adolescents”, Masconomet High School, Topsfield, MA
Special Education Department “Review of Psychotropic Medications used in Children &
Adolescents”, Peabody High School, Peabody, MA
Special Education Administrators, “The Role of Psychotropic Medications in Special
Education Students” The Landmark School, Prides Crossing, MA
Strengthening Family Ties: The Use of Psychotropic Medications in Children”,
Department of Mental Health, Beverly, MA
Children’s Mental Health Conference “An Update on Psychotropic Medications Used in
Children and Adolescents” Health and Education Services, Haverhill, MA
Pentucket Medical Associates “Depressive Disorders in Children and Adolescents”
Haverhill, MA
17
2000
2001
2001
2001
2001
2001
2001
2001
2002
2002
2002
2003
2003
2003
2003
2003
2004
2004
2004
2004
2004
2005
Special Education Parent Advocacy Committee, “An Overview of Psychiatric Disorders
in Children and Adolescents,” Marblehead, MA
Continuing Training, Full Day Symposia on “Update & Overview of Psychiatric
Medications Used in Children and Adolescents” to Department of Social Services,
Waltham, MA
School Nurses Conference, “Update on Pharmacotherapy of ADHD”, Salem, MA
CHAAD Parent Teacher Conference, “New Developments in the Treatment of ADHD”,
Farmington, CT
CHAAD Parent Teacher Conference, “Recent Developments in the Treatment of
ADHD”, Warwick, RI
Special Education Administrators, “Update on Psychotropic Medications in Special
Education Students” The Landmark School, Prides Crossing, MA
School Nurses Conference, “An Overview of Psychopathology and Pharmacotherapy in
Children and Adolescents” North Shore educational Consortium, Danvers, MA
Presentation to Regular and Special Education Departments of Somerville Charter
Schools, “Review of Psychopathology and Psychotropic Medications used in Children &
Adolescents”, Somerville, MA
Presentation to Case Collaborative Educational Staff “Use of Psychotropic Medications
in Children and Adolescents” Concord, MA
Special Education Administrators, “The Role of Psychotropic Medications in Special
Education Students” The Landmark School, Prides Crossing, MA
Presentation to Special Education Staff and School Guidance Personal “Overview of
Psychotropic Medications in Children and Adolescents”, Middleton, MA
Presentation sponsored by Family Resource Center, North Shore Medical Center, “A
History of ADHD and Update of Medications Used to Treat ADHD” Salem, MA
Presentation sponsored by National Alliance for the Mentally Ill, “Psychiatric
Medications in Children and Adolescents” Salem, MA
Presentation to sponsored by Parent Association of Northeast Educational Consortium
“Update on risk and Benefit of Psychiatric Medications in Children and Adolescents with
Neuropsychiatric Disorders” Danvers, MA
Special Education Administrators, “The Role of Psychotropic Medications in Special
Education Students” The Landmark School, Prides Crossing, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center,
“Pharmacotherapy of ADHD” Salem, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center,
“Pharmacotherapy of ADHD” Salem, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center,
“Mad Sad or Bad: Pediatric Mood Disorders” Salem, MA
Presentation sponsored by the Norman Read Trust, “Evaluation and Treatment of Anxiety
and Depression in Elementary School Students” Danvers, MA
Conference sponsored by Essex County District Attorney’s Office “Medical and Mental
Health Assessment in Adolescents at Risk” North Shore Medical Center Salem, MA
Presentation sponsored by the Cape Ann Department of Social Service and the School
Department of Beverly, MA “Overview of Psychiatric Medications Used in Children and
Adolescents” Salem, MA
Legislative Briefing, State House Commonwealth of Massachusetts “Impact of Child
Abuse and Neglect” for the Children’s Trust Fund
18
2005
2005
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2007
Presentation sponsored by the Family Resource Center, North Shore Medical Center
“Pharmacotherapy of ADHD” Danvers, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center
“Adolescent Depression and Suicide” Danvers, MA
Presentation “Adolescent Substance Abuse” sponsored by the Alcohol and Drug Abuse
Awareness Team Hamilton, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center
“Cannabis: Facts You Need to Know” Danvers, MA
Presentation “The Use of Psychiatric Medications in Children and Adolescents with
Autism” sponsored by the Autism Resource Center of the North Shore
Legislative Briefing, State House Commonwealth of Massachusetts “Importance of the
Prevention of Child Abuse and Neglect” for the Children’s Trust Fund
Conference sponsored by the Family Resource Center North Shore Medical Center
“Bipolar Disorder in Children and Adolescents” Danvers, MA
Conference sponsored by the Autism Support Center “Pharmacotherapy of Autism and
Related Conditions” Danvers, MA
Spring Symposium Mental Health Conditions in the Teenage Years: A Program for
Parents sponsored by the Mood and Anxiety Disorder Institute at Massachusetts General
Hospital “The Role of Medications and Psychotherapy” Boston, MA
Presentation sponsored by the Family Resource Center, North Shore Medical Center
“ADHD in Adolescents: Learning by Case Studies” Danvers, MA
Keynote Speaker Essex County Youth Forum: “Getting Kids What They Need:
Understanding the Neurobiology of Stress” Beverly Farms, MA
Keynote Speaker “Pathways to Success” for the Annual Benefit for the Institute for
Learning and Development of the Harvard School of Education Waltham, MA
Conference sponsored by TeamUp for Marblehead “The Real Risks: What Every
Parent Needs to Know About Adolescent Social Development, Substance Use &
Abuse” Marblehead, MA
Presentation to teachers from Ipswich Middle and High Schools “Taking Care of the
Teachers: Strategies for Teaching Today’s Youth” Ipswich, MA
Principal Clinical and Hospital Service Responsibilities
1992-95
1994-95
1995-97
1995-1998
1996199719971997-99
1998-
Clinical Fellow in Psychiatry, Massachusetts General Hospital, Harvard Medical School
Chief Resident, Acute Psychiatry Service, Massachusetts General Hospital
Clinical Fellow in Child Psychiatry, Massachusetts General and McLean Hospitals,
Harvard Medical School, Boston, MA
Staff, Correctional Health Care Solutions, Essex County House of Corrections
Middleton, MA
Staff, Pediatric Psychopharmacology Clinic, North Shore Children’s Hospital, Salem,
MA
Staff, Child Psychiatry, Massachusetts General and McLean Hospitals, Harvard Medical
School, Boston, MA
Director, Pediatric Psychopharmacology and Outpatient Mental Health Clinics, North
Shore Children’s Hospital, Salem, MA
Staff, Boston Emergency Services Team, Boston, MA
Co-director, Anxiety Treatment Center, North Shore Children’s Hospital, Salem, MA
19
1999200020042005-
Assistant in Psychiatry, Massachusetts General Hospital, Boston, MA
Director, Child and Adolescent Psychiatry, North Shore Medical Center, Salem, MA
Consultant, North Shore Educational Consortium, Beverly, MA
Medical Director, Massachusetts Child Psychiatry Access Project, North Shore Medical
Center
Original Reports:
1. Wilens, T., Biederman, J., Spencer, T., and Prince, J.: Pharmacotherapy of Adult ADHD: A
Review. (1995) Journal of Clinical Psychopharmacology, 15: 270-79.
2. Wilens, T., Prince, J., Biederman, J., Spencer, T., and Frances, R.: Attention-Deficit Hyperactivity
Disorder and Comorbid Substance Use Disorders in Adults. (1995) Psychiatric Services, 46: 761-65.
3. Prince J, Wilens T, Biederman J, Spencer T, Wozniak J. Clonidine for ADHD related sleep
disturbances: A retrospective evaluation of 62 patients. (1996) J Am Acad Child Adolesc Psychiatry:
35:599-605; also In Digest of Neurology and Psychiatry, Institute of Living, Hartford CT, Summer 1996;
also In ADHD Report: 4; 5, October 1996; also Focus on Psychiatry, 1994.
4. Wilens T, Biederman J, Prince J, Spencer T, Faraone S, Warburton R, Schleifer D, Geller D. Six
week, double blind, placebo controlled study of desipramine for adult attention deficit hyperactivity
disorder. Am J Psychiatry (1996); 153:1147-1153; also Journal Watch for Psychiatry, November 1996;
also Behavioral Health Outcomes 2: 1997.
5. Fishman, SM., Prince, JB. Herman, JB. and Cassem, NH.: Pocket-sized electronic clinical
referencing: a pilot study of physician acceptance and usefulness. MD Computing (1996) 13 (4): 310-3.
6. Bemporad, J., Prince, J., Wilens, T., and Schwartz, R.: ADD: The media as a referral source. (1997)
Harvard Review of Psychiatry 5(2): 82-90.
7. Wilens, T, Spencer, T, Prince, J. Diagnosing ADD in adults. (1997) Attention 3(4): 27-35.
8. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones, J, Harding M, Faraone, S, Seidman, L.:
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder (1998)
American. Journal of Psychiatry 155 (5): 693-695.
9. Biederman, J, Mick, E., Bostic, J., Prince, J., Daly, J., Wilens, T., Spencer, T., Garcia-Jetton, J.,
Russell, R., Wozniak, J., and Faraone, S.: The naturalistic course of pharmacologic treatment of children
with manic-like symptoms: A systematic chart review. (1998) J Clinical Psychiatry 59 (11): 628-637.
10. Cohen, L., Biederman, J., Wilens, T., Spencer, T., Faraone, S.V., Mick, E., Prince, J., and Flood,
J.G.: Desipramine Clearance in children and adolescents: Absence of effect of development and gender.
(1999) J Am Acad Child and Adolesc Psychiatry 38 (1): 79-85.
11. Wilens, T, Biederman, J., Spencer, T., Frazier, J., Prince, J., Bostic, J., Rater, M., Soriano, J., Hatch,
M., Sienna, M., Millstein, R., and Abrams, A.: Controlled trial of high dose pemoline for adults with
attention deficit hyperactivity disorder. (1999) J. Clinical Psychopharmacology 19 (3): 257-264.
20
12. Cohen, L., Prince, J., Biederman, J., Wilens, T. Faraone, S.V., Whitt, S., Mick, E., Spencer, T.,
Meyer, M., Polisner, D., and Flood, J.G.: Absence of effect of stimulants on the pharmacokinetics of
desipramine in children. (1999) Pharmacotherapy 19 (6): 746-752.
13. Biederman, J, Mick, E., Prince, J., Bostic, J., Daly, J., Wilens, T., Spencer, T., Garcia-Jetton, J.,
Russell, R., Wozniak, J., and Faraone, S.: Systematic chart review of the pharmacologic treatment of
comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. (1999) J. Child and
Adolescent Psychopharmacology. 9 (4): 247-256.
14. Wilens, TE, Biederman, J., Spencer, TJ, Bostic, J., Prince, J., Monuteaux, MC, Soriano, J, Fine, C.,
Abrams, A., Rater, M., and Polisner, D. A pilot controlled clinical trial of ABT-418, a cholinergic
agonist, in the treatment of adults with attention deficit hyperactivity disorder. (1999) Am J Psychiatry
156 (12): 1931-1937.
15. Prince, J, Wilens, T, Biederman, J, Spencer, T, Millstein, R, Polisner, D, and Bostic, J. A controlled
study of nortriptyline in children and adolescents with Attention Deficit Hyperactivity Disorder. J Child
and Adolescent Psychopharmacology (2000); 10 (3): 193-204.
16. Bostic, JQ, Biederman, J, Spencer, TJ, Wilens, TE, Prince, JB, Monuteaux, MC, Sienna, M,
Polisner, DA, and Hatch, M. Pemoline treatment of adolescents with attention deficit hyperactivity
disorder: a short-term trial. . J Child and Adolescent Psychopharmacology (2000); 10 (3): 20517. Wilens, TE, Biederman, J, Spencer, TJ, Prince, J. Adjunctive donepezil in attention deficit
hyperactivity disorder youth: case series. J Child and Adolescent Psychopharmacology (2000); 10 (3):
217-222.
18. Wilens T, Biederman J, Spencer T, Prince J, Solhkhah R, Polisner D, Parek A, Comeau S,
Monteaux M. A controlled clinical trial of bupropion SR for adults with ADHD. Am J
Psychiatry 2001; 158:282-288
19. Bostic, J., Prince, J., Brown, K., Place, S. “”A retrospective study of citalopram in adolescents with
depression” J Child and Adolescent Psychopharmacology; 2001; 11 (2): 159-166
20. Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone S, Rea J, Witcher J,
Zeras S. An open label dose-ranging study of atomoxetine in ADHD youth. Journal of Child and
Adolescent Psychopharmacology 2001: (11) 3: 251-265.
21. Spencer T, Wilens T, Biederman J, Prince J, Solhkhah R, Parek, A, Comeau S, Girard K. Efficacy
of mixed amphetamine salts in adults with ADHD. Arch Gen Psych, 2001: 58 (8): 775-82.
22. Mick, E., Biederman, J., Prince, J., Fischer, M.J., and Faraone, S.V.: “Impact of low birth weight on
attention-deficit/hyperactivity disorder” 2002 Journal of Developmental and Behavioral Pediatrics 23
(1): 16-22.
23. Wilens, T., Biederman, J., Mick, E., Spencer, T., Prince, J.: “Patterns of psychopathology and
dysfunction in clinically referred preschoolers” J. Dev. Behav. Pediatrics 2002 23 (1 Suppl): S31-6.
21
24. Dechant, E., Jellinek, M., Goodwin, J., Prince, J.: “Processing acute traumatic grief: Exacerbation of
posttraumatic stress disorder after September 11 in a 9-year-old boy” Harvard Review of Psychiatry
2002 (10): 231-41.
25. Prince, J., Bostic, J. , Monuteaux, M., Brown, K., Place, S. “Citalopram for the Treatment of
Adolescent Anxiety Disorders: A Pilot Study” Psychopharmacology Bulletin 2002 (36) 3:100-107.
26. Wilens T, Prince J, Spencer T, Van Patten S, Doyle R, Girard K, Hammerness P, Goldman S,
Brown S, and Biederman J. .An open trial of bupropion for the treatment of adults with attention deficit
hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003 Jul 1;54(1):9-16.
27. Spencer, T, Wilens, T, Biederman, J, Doyle, Surman, C, Prince, J, Mick, E, Aleardi, M, Herzig, K
and Faraone, S “A large, double-blind, randomized clinical trial of methylphenidate in the treatment of
adults with attention-deficit/hyperactivity disorder.” Biol Psychiatry. 2005 Mar 1;57(5):456-63.
28. Bostic, JQ, Rubin, DH, Prince, JB and Schlozman , S “Treatment of depression in children and
adolescents.” J Psychiatr Pract. 2005 May 11(3):141-54.
29. Solhkhah, R, Wilens, TE, Daly, J, Prince, JB, Van Patten, SL and Biederman, JB “Bupropion SR for
the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder
and mood disorders.” J Child Adolesc Psychopharmacol. 2005 Oct; 15(5): 777-86.
30. Nancy Rappaport, N, Prince, JB and Bostic, JQ “Lost in the Black Box: Juvenile Depression,
Suicide, and the FDA's Black Box” Journal of Pediatrics 2005 Dec 147 (6): 719-20
31. Prince, JB “Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents:
update on new stimulant preparations, atomoxetine, and novel treatments.” Child and Adolescent
Psychiatric Clinics of North America 2006 15(1): 13-50.
32. Wilens, TE, Prince, JB, Spencer, TJ and Biederman, J “Stimulants and Sudden Death: What is a
Physician to do?” Pediatrics 2006 118 (3): 1215-1219.
33. Bieerman, J, Spencer, TJ, Wilens, TE, Prince, JB and Faraone, SV “Treatment of ADHD with
Stimulant Medications: Response to Nissen Perspective in the New England Journal of Medicine”
Journal of the American Academy of Child and Adolescent Psychiatry 2006 45 (10): 1147-1150.
34. Nancy Rappaport, N, Bostic, JQ, Prince, JB and Jeliinek, M “Treating pediatric depression in
primary care: coping with the patients' blue mood and the FDA's black box” Journal of Pediatrics 2006
148 (5): 567-568.
35. Shapiro HL, Prince JB, Ireland R, Stein MT. “A dominating imaginary friend, cruelty to animals,
social withdrawal, and growth deficiency in a 7-year-old girl with parents with schizophrenia” Journal of
Developmental and Behavioral Pediatrics 2006 27 (3): 231-236.
36. Maalouf FT, Ziegler RG, Schlozman S and Prince JB “Bipolar disorder in a preschooler: long-term
ramifications of an early diagnosis and treatment” Harvard Review of Psychiatry 2006 NovDec;14(6):319-29.
22
37. Findling, RL, Newcorn, JH, Malone RP, Waheed, A, Prince, JB and Kratochvil, CJ
“Pharmacotherapy of Aggression in a 9-year-old with ADHD” Journal of the American Academy of
Child & Adolescent Psychiatry accepted anticipated publication in May 2007
Chapters and Monographs:
Prince, J. and Wilens, T.: Diagnosis and Treatment of Adult ADHD. A chapter in Attentional Deficits
and Hyperactivity in Children and Adults: Diagnosis, Treatment, and Management edited by P. Accardo,
T. Blondis, B. Whitman, and M.Stein (2000); Marcel Dekker, Inc. New York, NY.
Prince, J.: Stimulants, Beta-Adrenergic Blocking Agents, and Alpha-Adrenergic Blocking Agents. A
chapter in Massachusetts General Hospital Psychiatry Update & Board Preparation, eds T.A. Stern and
J.B. Herman, The McGraw-Hill Companies, 2000: 365-373.
Prince, J. and Wilens, T.: Pharmacotherapy of Adult ADHD. A chapter in Clinician’s Guide to Adult
ADHD: Assessment and Intervention eds S. Goldstein, and A. Teeter, Academic Press, San Diego, CA.
2002: 165-182.
Prince, J. and Wilens, T.: Medical Issues for Women with AD/HD: Pharmacologic Treatment. A
chapter in Understanding Women with AD/HD eds P. Quinn and K. Nadeau, Advantage Books, Silver
Spring, MD. 2002: 46-69.
Prince, J. and Wilens, T.E.: Medications Used in the Treatment of AD/HD. In Gender Issues and
AD/HD: Research, Diagnosis, and Treatment, eds K. Nadeau, and P. Quinn, Advantage Books, Silver
Spring, MD. 2002: 144-82.
Doyle, R. and Prince, J.: Clinical Diagnosis: Past, Present, and Future. In ADHD: Current Understanding
of Etiology, Diagnosis, & Neurobiology. ed J Biederman, Veritas Institute for Medical Education, Inc.
2002: 9-17.
Prince, J.: Stimulants, Atomoxetine, Beta-Adrenergic Blocking Agents, and Alpha-Adrenergic Blocking
Agents. A chapter in Massachusetts General Hospital Psychiatry Update & Board Preparation 2nd
Edition, eds T.A. Stern and J.B. Herman, The McGraw-Hill Companies, 2004: 365-373.
Prince, JB, Wilens, TE, Biederman, J and Spencer, TJ. Psychopharmacology for Children and
Adolescents. A chapter in Massachusetts General Hospital Handbook of General Hospital Psychiatry 5th
Edition, eds T.A. Stern, G.L. Fricchione, N.H. Cassem, M.S. Jellinek and J.F. Rosenbaum, Mosby,
2004: 231-268.
Prince, JB ADHD: History, Evolution and Social Impact. A chapter in ADHD Across the Lifespan: An
Evidenced-Based Understanding from Research to Clinical Practice, ed J Biederman, Veritas Institute
for Medical Education, Inc. and MedLearning, Inc., 2006: 1-26.
Prince, JB, Wilens, TE, Spencer, TJ and Biederman, J. Pharmacotherapy of ADHD in Adults. A chapter
in Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment 3rd Edition ed R.
A. Barkley, The Guilford Press, 2006: 704-736.
23
Prince, JB and Wilens, TE. Pharmacotherapy of ADHD and Comorbidites. A chapter in Attention-Defict
Disorders and Comorbidities in Children, adolescents and Adults 2nd Edition ed T.E. Brown, American
Psychiatric Press, Inc., in press
Abstracts:
1.
Prince, J., Wilens, T., Spencer, T., Wozniak, J., and Biederman, J.: Clonidine for ADHD-related
sleep disturbance: A systematic review of 47 cases. Scientific proceedings of the American Academy of
Child and Adolescent Psychiatrists, New York, 10: 45 (October 1994).
2.
Wilens, T., Prince, J., Spencer, T., Geller, D., Warburton, R., Moore, P., and Biederman, J.:
Double blind comparison of desipramine and placebo in adults with attention deficit hyperactivity
disorder: Preliminary results. Scientific proceedings of the American Academy of Child and Adolescent
Psychiatrists, New York, 10: 45 (October 1994).
3.
Spencer, T., Biederman, J., Wilens, T., and Prince, J.: Effectiveness and tolerability of
tomoxetine in adults with attention deficit hyperactivity disorder. Scientific proceedings of the American
Academy of Child and Adolescent Psychiatrists, New Orleans, 11: 109 (October 1995).
4.
Prince, J., Wilens, T., Biederman, J., and Spencer, T.: A naturalistic study of the
coadministration of psychostimulants and desipramine: Effects on serum desipramine levels. Scientific
proceedings of the American Academy of Child and Adolescent Psychiatrists, New Orleans, 11: 124
(October 1995).
5.
Wilens T, Prince J, Biederman J, Spencer T, Linehan C, Warburton R, Schleifer D, Moore P,
Geller D. Double blind comparison of desipramine and placebo in adults with attention deficit
hyperactivity disorder. Scientific proceedings of the American Psychiatric Association, Miami 1995;
148:227; and Scientific proceedings of the American Academy of Child and Adolescent Psychiatry, New
Orleans, 1995; 11:125.
6.
Wilens T, Biederman J, Spencer T, Prince J, Millstein R, Hatch M, Sorriano M et al., A double
blind comparison of pemoline and placebo for adults with ADHD: Preliminary analysis. American
Academy of Child and Adolescent Psychiatry, Philadelphia, 1996; 12:121.
7.
Daly J, Biederman J, Prince J, Wilens T, Soriano J, Russel R. The effects of psychopathology and
nortriptyline on autonomic control of the heart. American Academy of Child and Adolescent Psychiatry,
Philadelphia, 1996; 12: 130.
8.
Wilens T, Spencer T, Frazier, J, Prince J, Bostic, J, Hatch M, Abrantes A, Sorriano J, Sienna M,
Millstein R, Biederman, J. A double blind comparison of pemoline and placebo for adults with ADHD.
44th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada,
1997, 13:107.
9.
Bostic, J, Biederamn, J, Spencer, T, Wilens, T, Prince, J. Pemoline in Adolescents with
Attention-Deficit/Hyperactivity Disorder: Preliminary Findings. 44th Annual Meeting of the American
Academy of Child and Adolescent Psychiatry, Toronto, Canada, 1997, 13:149.
24
10.
Wilens T, Biederamn J, Spencer T, Bostic, J, Prince, J, Monuteaux M, Soriano J, Fine C, Abrams
A, Rater M. A controlled trial of ABT-418 for Attention-Deficit/Hyperactivity Disorder in Adults.
NCDEU, Boca Raton, 1998; 47:137; also 46th Annual Meeting of the American Academy of Child and
Adolescent Psychiatry, Chicago, 1999 15:127.
11.
Wilens T, Biederman J, Spencer T, Prince J, Solhkhah R, Polisner D, Parek, A, Comeau S,
Monteaux M. A controlled clinical trial of bupropion SR for adults with ADHD. 39th Annual meeting of
NCDEU, Boca Raton, FL, 1999; 29; also 46th Annual Meetings of the American Academy of Child and
Adolescent Psychiatry, Chicago, 1999.
12.
Wilens T, Prince J, Spencer T, Goldman S, Doyle R, Biederman J. Bupropion SR in adults with
ADHD and bipolar disorder. Annual Meeting of the American Academy of Child and Adolescent
Psychiatry, New York, P33, 2000; also 155th Annual meetings of the American Psychiatric Association,
Philadelphia, May 2002 (abs Nr 419); NCDEU, Boca Raton, May 2002 (II-84).
13. Solhkhah R, Wilens T, Prince JB, Daly J, and Biederman J: Bupropion Sustained
Release for Substance Abuse, ADHD, and Mood Disorders in Adolescents. Annual Meeting of
the American Psychiatric Association, New Orleans, 2001; also 48th Annual meetings of the
American Academy of Child and Adolescent Psychiatry, Honolulu, October 2001
14.
Bostic, J.Q., Prince, J., Brown, K.and Place, S.: Citalopram in Adolescents with Mood and
Anxiety Disorders: A Chart Review. NCDEU, Phoenix, 2001; also 53rd Institute on Psychiatric
Services, Orlando, 2001
15.
Cohen, L.G., Doyle, R.L., Prince, J.B., Wozniak, J. Wilens, T.E., Spencer, T.J.,Biederman, J.:
Pharmacoepidemiology of Citalopram in Youth with Mood Disorders. NCDEU, Phoenix, 2001
16.
Wilens T, Prince J, Murphy K, Biederman J, Spencer T, Monuteaux M, Goldman S, Brown S,
Van Patten S. Bupropion SR treatment study in adults with ADHD and substance abuse. 48th Annual
meetings of the American Academy of Child and Adolescent Psychiatry, Honolulu, October 2001; also
155th Annual meetings of the American Psychiatric Association, Philadelphia, May 2002 (abs Nr 222);
NCDEU, Boca Raton, June 2002 (I-48).
17.
Doyle R, Cohen L, Prince J, Wozniak J, Wilens T, Spencer T, Biederman J. Influence of gender
on the pharmacotherapy of mood disorders with citalopram. 48th Annual meetings of the American
Academy of Child and Adolescent Psychiatry, Honolulu, October 2001.
18.
Wilens T, Biederman J, Monuteaux M, Gunawardene S, Wong J, Brown S, Wozniak J, Spencer
T, Prince J, Doyle R. Clinical characteristics of adults with ADHD and bipolar disorder. 48th Annual
meetings of the American Academy of Child and Adolescent Psychiatry, Honolulu, October 2001.
Manuscripts Submitted/In Preparation:
1
Prince, J., Wilens, T., Biederman, J., Daly, J., Polisner, D., Neft, D., and Keane, D “Autonomic
control of the heart in 20 children and adolescents treated with desipramine” (submitted Journal of Child
and Adolescent Psychopharmacology, August 2005)
25
2.
Prince, J., Wilens, T., Biederman, J et al. . “A Open Clinical Trial of Bupropion for
Attention-Deficit/Hyperactivity Disorder in Adults with Substance Use Disorders (submitted
Drug and Alcohol Dependence, August 2005)
3.
Prince, J. “Catecholamine Dysfunction in Attention Deficit Hyperactivity Disorder: An
Update” (anticipated submission to Journal of Clinical Psychiatry, January 2007)
4.
Prince, J., Jacobs, D “Pediatric Clinician’s Guide to Screening for Depression, Anxiety
and Suicide” (manuscript in preparation)